Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Product Launch

23 Sep 2009 07:00

RNS Number : 4943Z
Imaginatik PLC
23 September 2009
 



23 September 2009

Imaginatik plc

("Imaginatik" or the "Company")

Launch of ChemBioConnect

CambridgeSoft and Imaginatik launch Visual Collaboration Tool for Scientists

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaboration software, announces the launch of ChemBioConnect, an online collaboration tool for use by researchers in the chemistry, biotechnology and pharmaceutical industries.

Developed in conjunction with CambridgeSoft, ChemBioConnect allows scientists to draw, view, edit, archive and search chemical structures and biological systems in a secure, robust collaboration and idea management environment. The resource effectively allows for collaborative problem-solving among scientists by combining CambridgeSoft's chemically intelligent visual toolsets with Imaginatik's research-based, enterprise-scale system, comprised of software, services and a deep understanding of how human networks operate. This offering is targeted to meet the needs of research and development professionals in the areas of pharmaceuticals, bioscience, biotechnology, chemistry and food science.

"Professional chemists think and communicate visually, whether doodling on paper, working in teams at a whiteboard, or keeping a notebook," said Dr. Robin Spencer, Senior Research Fellow at Pfizer, Inc. "At Pfizer we have seen that marrying the ability to work visually with a secure collaborative innovation environment like ChemBioConnect gives our scientists a scalable and secure new way to capture ideas and solve challenging problems."

"Collaboration is vital in all forms of business activity, and chemistry and biology are not exceptions to this rule," said Mark Turrell, CEO of Imaginatik. "ChemBioConnect is the first in a series of industry specific modules of our core collaboration software platform, Idea Central, which we intend to launch in the years ahead, supporting our growth and market leadership position." 

"We are pleased to be working together with Imaginatik," said Michael G. Tomasic, President and CEO of CambridgeSoft. "With this collaboration we are ensuring that our customers benefit from the integration of CambridgeSoft's leading chemical and biological drawing software, ChemBioDraw, with Imaginatik's innovation engine to drive collaborative problem solving for new research insights and higher efficiency."

ChemBioConnect is being sold by Imaginatik with support from CambridgeSoft.

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik is the leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the leading companies in the world use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with its highly configurable web-based software and experienced consulting team.

A World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK, Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective problem solving. The company collaborates with several academic institutions including the IXL Center at Hult International Business School. Imaginatik is publicly traded on the London Stock Exchange [AIM:IMTK.L].

For further information please visit http://www.imaginatik.com

About CambridgeSoft

CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and scientific research organizations. Software products include enterprise, workgroup and desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, with knowledge management, chemical and biological informatics, and scientific database solutions. Web sites include ChemBioFinder.Com and ChemBioNews.Com for indexed database content and news, and SciStore.Com for e-commerce. CambridgeSoft has offices in the United StatesEurope and Asia Pacific. For more information, please go to www.cambridgesoft.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUUPPBUPBGQP
Date   Source Headline
28th Jul 20154:07 pmRNSHolding(s) in Company
24th Jul 201512:50 pmRNSHolding(s) in Company
21st Jul 20155:31 pmRNSHolding(s) in Company
20th Jul 20157:00 amRNSSubscription and Director Dealings
15th Jul 20157:00 amRNSFinal Results
10th Jul 20159:23 amRNSHolding(s) in Company
1st Jul 20157:00 amRNSContract Win
29th Jun 20155:11 pmRNSHolding(s) in Company
29th Jun 20155:10 pmRNSHolding(s) in Company
29th Jun 201510:30 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
23rd Jun 20155:15 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSMarket Update
1st Jun 20152:38 pmRNSResult of General Meeting
15th May 20157:00 amRNSPosting of Circular
14th May 20157:00 amRNSProposed Issue of Equity
13th Apr 20157:00 amRNSContract Wins
30th Mar 20157:00 amRNSContract Extension
16th Feb 20157:00 amRNSContracts win
11th Feb 20158:05 amRNSTrading Update
19th Jan 20157:00 amRNSDirector Loan
22nd Dec 201410:30 amRNSGrant of Options
17th Dec 20147:00 amRNSFive Year Contract Win
16th Dec 20147:00 amRNSContract Win
8th Dec 20147:00 amRNSInterim Results
19th Nov 20147:00 amRNSDirectorate Change
14th Nov 201411:52 amRNSBlocklisting Interim Review
24th Oct 20147:00 amRNSIssue of Equity/Director's Dealing
7th Oct 20145:04 pmRNSDirector/PDMR Shareholding
27th Aug 201410:50 amRNSHolding(s) in Company
21st Aug 20141:31 pmRNSDirector/PDMR Shareholding
18th Aug 20141:37 pmRNSHolding(s) in Company
14th Aug 20141:38 pmRNSResult of AGM
22nd Jul 20147:00 amRNSProposed Share Consolidation and Notice of AGM
1st Jul 20147:00 amRNSFinal Results
16th May 201411:40 amRNSHolding(s) in Company
15th May 20148:50 amRNSBlocklisting Interim Review
13th May 201411:47 amRNSHolding(s) in Company
12th May 20144:14 pmRNSResult of General Meeting and Exercise of Options
25th Apr 20147:00 amRNSProposed Placing and Subscription
14th Apr 20147:00 amRNSContract Wins and Trading Update
18th Mar 20147:00 amRNSContract Wins
28th Feb 201410:35 amRNSDirector's Dealing
26th Feb 201412:39 pmRNSDirector's Dealing
19th Dec 20133:38 pmRNSHolding(s) in Company
18th Dec 20137:00 amRNSExercise and Grant of Options
13th Dec 20137:00 amRNSContract Extension
3rd Dec 20137:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.